The relation of serum γ-glutamyl transferase levels and coronary collateral circulation in patients with chronic coronary total occlusion

Coronary Artery Disease

Volumn 24, Issue 4, 2013, Pages 298-302

  Sarli, Bahadir ^a   Baktir, Ahmet O ^a   Saglam, Hayrettin ^a   Arinc, Huseyin ^a   Kurtul, Serkan ^a   Akpek, Mahmut ^b   Kaya, Mehmet G ^b  

^a Kayseri Education and Research Hospital ^*  (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

Author keywords

gluthamyl transferase; Chronic total occlusion; Coronary collateral circulation

Indexed keywords

CREATININE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY CHRONIC TOTAL OCCLUSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART INFARCTION; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE VOLUME;

AGED; BIOLOGICAL MARKERS; CHRONIC DISEASE; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY OCCLUSION; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO;

EID: 84877042749     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32835f301d     Document Type: Article

References (36)

1. Kahn JK. Angiographic suitability of catheter revascularization of total coronary occlusions in patients from a community hospital setting. Am Heart J 1993; 126:561-564.
2. Christofferson RD, Lehmann KG, Martin GV, Every N, Caldwell JH, Kapadia SR. Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol 2005; 95:1088-1091.
3. Matsuo Y, Imanishi T, Hayashi Y, Tomobuchi Y, Kubo T, Hano T, et al. The effect of endothelial progenitor cells on the development of collateral formation in patients with coronary artery disease. Intern Med 2008; 47:127-134.
4. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, et al. Influence of coronary collaterals on myocardial infarct size in humans: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial: the TIMI investigators. Circulation 1991; 83:739-746.
5. Hirai T, Fujita M, Nakajima H, Asanoi H, Yamanishi K, Ohno A, et al. Importance of collateral circulation for prevention of left ventricular aneurysm formation in acute myocardial infarction. Circulation 1989; 79:791-796.
6. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Hata T, et al. Comparison of the cardioprotective effect of prodromal angina pectoris and collateral circulation in patients with a first anterior wall acute myocardial infarction. Am J Cardiol 2005; 95:622-625.
7. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38:263-355.
8. Aksakal E, Tanboga IH, Kurt M, Kayg?n MA, Kaya A, Isik T, et al. The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease. Atherosclerosis 2012; 221:596-601.
9. Dogan A, Icli A, Aksoy F, Varol E, Erdogan D, Ozaydin M, et al. Gammaglutamyltransferase in acute coronary syndrome patients without ST elevation and its association with stenotic lesion and cardiac events. Coron Artery Dis 2012; 23:39-44.
10. Akpek M, Elcik D, Kalay N, Yarlioglues M, Dogdu O, Sahin O, et al. The prognostic value of serum gamma glutamyl transferase activity on admission in patients with STEMI undergoing primary PCI. Angiology 2012; 63:579-585.
11. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5:587-592.
12. Heaps CL, Parker JL. Effects of exercise training on coronary collateralization and control of collateral resistance. J Appl Physiol 2011; 111:587-598.
13. Berry C, Balachandran KP, L'Allier PL, Lespe rance J, Bonan R, Oldroyd KG. Importance of collateral circulation in coronary heart disease. Eur Heart J 2007; 28:278-291.
14. Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi SF, Zbinden S, et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation 2007; 116:975-983.
15. Cohen M, Sherman W, Rentrop KP, Gorlin R. Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects. J Am Coll Cardiol 1989; 13:297-303.
16. Fujita M, Tambara K. Recent insights into human coronary collateral development. Heart 2004; 90:246-250.
17. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, et al. Gammaglutamyltransferase and diabetes-a 4 year follow-up study. Diabetologia 2003; 46:359-364.
18. Turgut O, Yilmaz A, Yalta K, Karadas F, Yilmaz MB. Gamma glutamyl transferase is a promising biomarker for cardiovascular risk. Med Hypotheses 2006; 67:1060-1064.
19. Lee DH, Gross M, Jacobs DR. The association of serum carotenoids and tocopherols with gamma glutamyltransferase the CARDIA study. Clin Chem 2004; 50:582-588.
20. Nakajima T, Ohta S, Fujita H, Murayama N, Sato A. Carbohydrate-related regulation of the ethanol induced increase in serum gamma-glutamyl transpeptidase activity in adult men. Am J Clin Nutr 1994; 60:87-92.
21. Koc F, Kalay N, Ardic I, Ozbek K, Celik A, Ceyhan K, et al. Antioxidant status and levels of antioxidant vitamins in coronary artery ectasia. Coron Artery Dis 2011; 22:306-310.
22. Lee DH, Jacobs DR. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 2005; 178:327-330.
23. Lee DH, Blomhoff R, Jacobs DR. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004; 38:535-539.
24. Paolicchi A, Minotti G, Tonarelli P, Tongiani R, De Cesare D, Mezzetti A, et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation-a potential mechanism in atherosclerosis. J Investig Med 1999; 47:151-160.
25. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49:1358-1366.
26. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995; 142:699-708.
27. Karlson BW,Wiklund O, Hallgren P, Sjo lin M, Lindqvist J, Herlitz J. Ten-year mortality among patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia. J Intern Med 2000; 247:449-456.
28. Brenner H, Rothenbacher D, Arndt V, Schuberth S, Fraisse E, Fliedner TM. Distribution, determinants, and prognostic value of gammaglutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany. Prev Med 1997; 26:305-310.
29. Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, et al. Beta-lipoprotein-and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 2006; 186:80-85.
30. Duran M, Gunebakmaz O, Uysal OK, Celik A, Yarlioglues M, Karakaya E, et al. Increased gamma-glutamyl transferase level is associated with absence of coronary collateral vessels in patients with acute coronary syndrome: an observational study. Anadolu Kardiyol Derg 2012; 12:652-658.
31. Hattan N, Chilian WM, Park RF, Rocic P. Restoration of coronary collateral growth in the Zucker obese rat: impact of VEGF and ecSOD. Basic Res Cardiol 2007; 102:217-223.
32. Pung YF, Chilian WM. Corruption of coronary collateral growth in metabolic syndrome: role of oxidative stress. World J Cardiol 2010; 2: 421-427.
33. Laughlin MH, Bowles DK, Duncker DJ. The coronary circulation in exercise training. Am J Physiol Heart Circ Physiol 2012; 302:10-23.
34. Dogdu O, Yarlioglues M, Kaya MG, Ardic I, Akpek M, Senarslan O, et al. Relationship between psychosocial status, diabetes mellitus, and left ventricular systolic function in patients with stable multivessel coronary artery disease. Cardiol J 2012; 19:249-255.
35. Robinson D,Whitehead TP. Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening. Ann Clin Biochem 1989; 26:393-400.
36. Perry IJ,Wannamethee SG, Shaper AG. Prospective study of serum gammaglutamyltransferase and risk of NIDDM. Diabetes Care 1998; 21:732-737.